Anders Jarneborn

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Rheumatoid Arthritis

Peripheral Blood

Biofilm Formation

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Anders Jarneborn, Zhicheng Hu, Meghshree Deshmukh, Pradeep Kumar Kopparapu, Tao Jin
Tofacitinib Treatment Suppresses CD4+ T-Cell Activation and Th1 Response, Contributing to Protection against Staphylococcal Toxic Shock. International journal of molecular sciences 25 (13) (2024)
Anders Jarneborn, Zhicheng Hu, Meghshree Deshmukh, Pradeep Kumar Kopparapu, Tao Jin
Tofacitinib Treatment Suppresses CD4+ T-Cell Activation and Th1 Response, Contributing to Protection against Staphylococcal Toxic Shock. International journal of molecular sciences 25 (13) (2024)
Anders Jarneborn, Zhicheng Hu, Meghshree Deshmukh, Pradeep Kumar Kopparapu, Tao Jin
Tofacitinib Treatment Suppresses CD4+ T-Cell Activation and Th1 Response, Contributing to Protection against Staphylococcal Toxic Shock. International journal of molecular sciences 25 (13) (2024)
Manli Na, Zhicheng Hu, Majd Mohammad, Mariana do Nascimento Stroparo, Abukar Ali, Ying Fei, Anders Jarneborn, Peter Verhamme, Olaf Schneewind, Dominique Missiakas, Tao Jin
The Expression of von Willebrand Factor-Binding Protein Determines Joint-Invading Capacity of Staphylococcus aureus, a Core Mechanism of Septic Arthritis. mBio 11 (6) (2020)
Majd Mohammad, Minh-Thu Nguyen, Cecilia Engdahl, Manli Na, Anders Jarneborn, Zhicheng Hu, Anna Karlsson-Bengtsson, Rille Pullerits, Abukar Ali, Friedrich Götz, Tao Jin
The YIN and YANG of lipoproteins in developing and preventing infectious arthritis by Staphylococcus aureus. PLoS pathogens 15 (6) (2019)